Buy UKBS Anadrol (Oxymetholone) 50mg x 100 tabs

Price: $59.00

Qty: Add to Cart

(Oxymetholone)

Oxymetholone is a potent oral anabolic steroid that first appeared in the 1960’s under the trade names Anadrol 50 (Syntex) and Androyd (Park Davis & co.) To this day the Oxymetholone hormone is normally referred to as Anadrol in most circles. When the steroid was first released it was touted as holding numerous therapeutic benefits. The range of benefits included the treatment gastrointestinal disease, osteoporosis and anemia, as well as treating chronic underweight issues and combating any catabolic disease or condition.

Over the years Anadrol has fallen under heavy scrutiny from the U.S. FDA as have most anabolic steroids. Currently, the Oxymetholone hormone is only approved in the U.S. for the treatment of anemia, as well as muscle wasting diseases like HIV and AIDS. The compound is also no longer manufactured by Park Davis & co. and Syntex would sell its right to Unimed Pharmaceuticals in the late 1990’s eventually finding its way to Alevan Pharmaceuticals in 2006.

The Oxymetholone hormone known, as Anadrol, is a dihydrotestosterone (DHT) derived anabolic steroid that is closely related to methyldihydrotestosterone. Specifically, Oxymetholone is DHT with an added 2-hydroxymethylene group, which greatly enhances its anabolic activity. It is also a C17-alpha alkylated (C17-aa) anabolic steroid. This refers to a structural change of the hormone at the 17^th carbon position that allows it to be orally ingested. Without the change the majority of the hormone would be destroyed before any benefit could be obtained. Unfortunately, this also makes Anadrol toxic to the liver (see side effects section).

Anadrol carries an extremely high anabolic rating that is three times greater than testosterone. However, its androgenic rating is rather low, but also a bit misleading. Anadrol has a tendency to be more androgenic than its rating would imply. The metabolism of this steroid easily removes the 2-hydroxymethylene group, at least in part, thereby reducing the hormone to methyldihdrotestosterone.